FEBUXOSTAT

sanis health inc🇨🇦 Health Canada

Approval Id: c67b0f7d2dd2ed45
Drug Approval Canada Name: FEBUXOSTAT
Product Name: FEBUXOSTAT
Status: Marketed
Status Date: 2023-12-07
Original Market Date: 2023-12-07
Din: 02539837
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 92:16.00
Atc Original: M04AA03 FEBUXOSTAT
Atc Name: m 04 aa 03
Aig Number: 0152809001
Company Name: sanis health inc
Company Address: 1 Presidents Choice Circle, Brampton, Ontario, Canada, L6Y 5S5

FEBUXOSTAT (FEBUXOSTAT HEMIHYDRATE)

80 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

c67b0f7d2dd2ed45

Type

Standard